111 related articles for article (PubMed ID: 33768398)
1. Comparison of Aggressive Planned Salvage Surgery Versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma.
Shiraishi O; Yasuda T; Kato H; Momose K; Hiraki Y; Yasuda A; Shinkai M; Kimura Y; Imano M
Ann Surg Oncol; 2021 Oct; 28(11):6366-6375. PubMed ID: 33768398
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
[TBL] [Abstract][Full Text] [Related]
3. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
Markar S; Gronnier C; Duhamel A; Pasquer A; Théreaux J; du Rieu MC; Lefevre JH; Turner K; Luc G; Mariette C
J Clin Oncol; 2015 Nov; 33(33):3866-73. PubMed ID: 26195702
[TBL] [Abstract][Full Text] [Related]
4. Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer: National Population-based Cohort Study.
Kamarajah SK; Phillips AW; Hanna GB; Low D; Markar SR
Ann Surg; 2022 Mar; 275(3):526-533. PubMed ID: 32865948
[TBL] [Abstract][Full Text] [Related]
5. Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis.
Markar SR; Karthikesalingam A; Penna M; Low DE
Ann Surg Oncol; 2014 Mar; 21(3):922-31. PubMed ID: 24212722
[TBL] [Abstract][Full Text] [Related]
6. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma.
Okamura A; Hayami M; Kozuki R; Takahashi K; Toihata T; Imamura Y; Mine S; Watanabe M
Esophagus; 2020 Jan; 17(1):59-66. PubMed ID: 31595397
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
[TBL] [Abstract][Full Text] [Related]
8. ASO Author Reflections: Comparison of Aggressive Planned Salvage Surgery versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma.
Shiraishi O
Ann Surg Oncol; 2021 Oct; 28(11):6376-6377. PubMed ID: 33830358
[No Abstract] [Full Text] [Related]
9. [IMRT-based preoperative neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma (ESCC): an analysis of outcome and prognosis].
Men Y; Hui ZG; Liang J; Feng QF; Chen DF; Zhang HX; Xiao ZF; Zhou ZM; Wang LH
Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):682-6. PubMed ID: 27647401
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
11. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma.
Hirohata R; Hamai Y; Hihara J; Emi M; Kurokawa T; Yoshikawa T; Ohsawa M; Kitasaki N; Okada M
World J Surg; 2022 Aug; 46(8):1934-1943. PubMed ID: 35508816
[TBL] [Abstract][Full Text] [Related]
13. Association of preoperative inflammation-based prognostic score with survival in patients undergoing salvage esophagectomy.
Sugawara K; Mori K; Yagi K; Aikou S; Uemura Y; Yamashita H; Seto Y
Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30535140
[TBL] [Abstract][Full Text] [Related]
14. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors and Appropriate Lymph Node Dissection in Salvage Esophagectomy for Locally Advanced T4 Esophageal Cancer.
Ohkura Y; Ueno M; Iizuka T; Udagawa H
Ann Surg Oncol; 2019 Jan; 26(1):209-216. PubMed ID: 30465220
[TBL] [Abstract][Full Text] [Related]
16. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
[TBL] [Abstract][Full Text] [Related]
17. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
18. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma.
Murakami Y; Hamai Y; Emi M; Hihara J; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Kimura T; Okada M; Nagata Y
J Radiat Res; 2018 Sep; 59(5):616-624. PubMed ID: 29939306
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.
Yang H; Liu H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Lordick F; D'Journo XB; Cerfolio RJ; Korst RJ; Novoa NM; Swanson SJ; Brunelli A; Ismail M; Fernando HC; Zhang X; Li Q; Wang G; Chen B; Mao T; Kong M; Guo X; Lin T; Liu M; Fu J;
J Clin Oncol; 2018 Sep; 36(27):2796-2803. PubMed ID: 30089078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
